Literature DB >> 24524092

The colony-stimulating factors and cancer.

Donald Metcalf1.   

Abstract

The colony-stimulating factors (CSFs) are the master regulators of granulocyte and macrophage populations. There are four different aspects of the connection between the CSFs and cancer: (a) the CSFs can accelerate the regeneration of protective white cells damaged by chemotherapy; (b) the CSFs can mobilize stem cells to the peripheral blood in convenient numbers for transplantation; (c) the CSFs can enhance anticancer immune responses and (d) the CSFs are potentially involved in the genesis of the myeloid leukemias.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24524092      PMCID： PMC3918448          DOI： 10.1158/2326-6066.CIR-13-0151

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN： 2326-6066            Impact factor:   11.151


  33 in total

1.  Multipotential hematopoietic blast colony-forming cells exhibit delays in self-generation and lineage commitment.

Authors:  Donald Metcalf; Ashley Ng; Sandra Mifsud; Ladina Di Rago
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

2.  Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells.

Authors:  E R Stanley; P M Heard
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

3.  Purification and properties of colony-stimulating factor from mouse lung-conditioned medium.

Authors:  A W Burgess; J Camakaris; D Metcalf
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

4.  Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo.

Authors:  B I Lord; G Molineux; Z Pojda; L M Souza; J J Mermod; T M Dexter
Journal:  Blood       Date:  1991-05-15       Impact factor: 22.113

5.  Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor.

Authors:  N A Nicola; D Metcalf; M Matsumoto; G R Johnson
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

6.  Procedures for the purification of interleukin 3 to homogeneity.

Authors:  J N Ihle; J Keller; L Henderson; F Klein; E Palaszynski
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Hemopoietic responses in mice injected with purified recombinant murine GM-CSF.

Authors:  D Metcalf; C G Begley; D J Williamson; E C Nice; J De Lamarter; J J Mermod; D Thatcher; A Schmidt
Journal:  Exp Hematol       Date:  1987-01       Impact factor: 3.084

8.  Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.

Authors:  M A Socinski; S A Cannistra; A Elias; K H Antman; L Schnipper; J D Griffin
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

9.  Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation.

Authors:  F Dong; C van Buitenen; K Pouwels; L H Hoefsloot; B Löwenberg; I P Touw
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

10.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307
View more
  20 in total

Review 1.  Therapy-related acute myeloid leukemia and its prevention.

Authors:  Gennady Belitsky; Timur Fetisov; Kirill Kirsanov; Ekaterina Lesovaya; Olga Vlasova; Marianna Yakubovskaya
Journal:  Am J Blood Res       Date:  2020-12-15

2.  Toxicity-Related Factors Associated With Use of Services Among Community Oncology Patients.

Authors:  Jordan M Harrison; Philip J Stella; Beth LaVasseur; Paul T Adams; Lauren Swafford; JoAnn Lewis; Kari Mendelsohn-Victor; Christopher R Friese
Journal:  J Oncol Pract       Date:  2016-07-12       Impact factor: 3.840

Review 3.  Concise Review: Advanced Cell Culture Models for Diamond Blackfan Anemia and Other Erythroid Disorders.

Authors:  Anna Rita Migliaccio; Lilian Varricchio
Journal:  Stem Cells       Date:  2017-12-05       Impact factor: 6.277

Review 4.  Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects.

Authors:  Chiara Crotti; Elena Agape; Andrea Becciolini; Martina Biggioggero; Ennio Giulio Favalli
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

5.  SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis.

Authors:  Anamika Gupta; Manju N Jayakumar; Mohamed A Saleh; Meganathan Kannan; Rabih Halwani; Rizwan Qaisar; Firdos Ahmad
Journal:  Life Sci       Date:  2022-06-11       Impact factor: 6.780

6.  Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF).

Authors:  Hartmut Link
Journal:  Support Care Cancer       Date:  2022-09       Impact factor: 3.359

Review 7.  Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance.

Authors:  Astik Priya; Shivani Yadav; Diksha R Borade; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-10-21       Impact factor: 4.505

Review 8.  Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date.

Authors:  Chiara Crotti; Maria Gabriella Raimondo; Andrea Becciolini; Martina Biggioggero; Ennio Giulio Favalli
Journal:  Drug Des Devel Ther       Date:  2017-01-13       Impact factor: 4.162

9.  PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers.

Authors:  Hsuan-Ming Yao; Faith D Ottery; Troy Borema; Stuart Harris; Jeffrey Levy; Tom B May; Shahrzad Moosavi; Jeffrey Zhang; Martin Summers
Journal:  BioDrugs       Date:  2019-04       Impact factor: 5.807

Review 10.  Improving Immunotherapy Through Glycodesign.

Authors:  Matthew J Buettner; Sagar R Shah; Christopher T Saeui; Ryan Ariss; Kevin J Yarema
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.